More recently, Park et al. developed hexagonal iron oxide nanoparticles coated with a peptide targeting vascular endothelial growth factor receptor-2 (VEGFR-2) for the targeted imaging and treatment of endometriosis (Park et al., 2022). The gene discussed is KDR; the disease is endometriosis.